3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Interventions
Blood Specimen Collection
53
Surveys and Questionnaires
49
Specimen Handling
29
Observation
15
Radiotherapy
14
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
11
Interviews as Topic
11
Data Collection
11
Drug Therapy
9
darolutamide
8
Biopsy
8
palbociclib
7
Watchful Waiting
7
Tomography, X-Ray Computed
7
Standard of Care
7
ribociclib
6
Magnetic Resonance Imaging
6
Bevacizumab
6
trastuzumab deruxtecan
5
Ultrasonography
5
Restraint, Physical
5
Radiofrequency Ablation
5
Patient Reported Outcome Measures
5
Mental Status and Dementia Tests
5
Mastectomy, Segmental
5
Mass Screening
5
Genetic Testing
5
Breath Tests
5
enzalutamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Social Determinants of Health
×
90 days
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled